Literature DB >> 14501853

Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study.

Jörg C Gerlach1, Kerim Mutig, Igor M Sauer, Petra Schrade, Ekaterina Efimova, Tim Mieder, Götz Naumann, Andreas Grunwald, Gesine Pless, Antoni Mas, Sebastian Bachmann, Peter Neuhaus, Katrin Zeilinger.   

Abstract

INTRODUCTION: The development of a bioreactor providing a three-dimensional network of interwoven capillary membranes with integrated oxygenation and decentralized mass exchange enables the culture of primary human liver cells from discarded donor organs for extracorporeal liver support.
METHODS: Primary liver cells were isolated from 54 discarded organs (donor age 56.7+/-13.2 years). Between 2.8x10(10) and 6.4x10(10) parenchymal cells (PC) were cocultured with nonparenchymal cells (NPC) of the same organ in bioreactors (n=36). The metabolic activity of the cells was regularly determined during culture. The cell morphology and ultrastructure were investigated after culture periods of 1 to 5 weeks.
RESULTS: Cell metabolism was maintained over at least 3 weeks after a phase of adaptation lasting 2 to 3 days. Through the use of transmission electron microscopy and immunohistochemistry, it was demonstrated that PC and NPC spontaneously formed tissue-like structures. Vascular cavities (CD 31 immunoreactivity [IR]) and bile duct-like channels (CK 19 IR), both exhibiting proliferation activity (Ki-67 IR), were regularly distributed. Some of the bile duct-like channels showed similarities to the Canals of Hering found in the natural liver. Cells expressing morphologic and antigenic characteristics of adult liver stem cells (CD 34 IR and c-kit IR) and areas with cells that showed both hepatocyte and biliary characteristics were detected.
CONCLUSION: The results show that primary human liver cells obtained from discarded donor organs recover and can be maintained in bioreactors for clinical liver support therapy. In addition, initial observations on adult liver stem-cell culture in bioreactors are presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501853     DOI: 10.1097/01.TP.0000083319.36931.32

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

1.  Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells.

Authors:  Greggory J Housler; Toshio Miki; Eva Schmelzer; Christopher Pekor; Xiaokui Zhang; Lin Kang; Vanessa Voskinarian-Berse; Stewart Abbot; Katrin Zeilinger; Jörg C Gerlach
Journal:  Tissue Eng Part C Methods       Date:  2011-12-28       Impact factor: 3.056

2.  Dynamic 3D culture promotes spontaneous embryonic stem cell differentiation in vitro.

Authors:  Jörg C Gerlach; Mariah Hout; Josefina Edsbagge; Petter Björquist; Marc Lübberstedt; Toshio Miki; Harald Stachelscheid; Eva Schmelzer; Gerald Schatten; Katrin Zeilinger
Journal:  Tissue Eng Part C Methods       Date:  2010-02       Impact factor: 3.056

3.  Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology.

Authors:  Jia Dong; Carl-Fredrik Mandenius; Marc Lübberstedt; Thomas Urbaniak; Andreas K N Nüssler; Daniel Knobeloch; Jörg C Gerlach; Katrin Zeilinger
Journal:  Cytotechnology       Date:  2008-10-07       Impact factor: 2.058

4.  Cell therapeutic options in liver diseases: cell types, medical devices and regulatory issues.

Authors:  Andreas K Nussler; Katrin Zeilinger; Lilianna Schyschka; Sabrina Ehnert; Jörg C Gerlach; Xueying Yan; Serene M L Lee; Maren Ilowski; Wolfgang E Thasler; Thomas S Weiss
Journal:  J Mater Sci Mater Med       Date:  2011-04-03       Impact factor: 3.896

Review 5.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

6.  Real-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay.

Authors:  Daniel Mueller; Georg Tascher; Georg Damm; Andreas K Nüssler; Elmar Heinzle; Fozia Noor
Journal:  Cytotechnology       Date:  2012-07-25       Impact factor: 2.058

Review 7.  Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.

Authors:  Avner Ehrlich; Daniel Duche; Gladys Ouedraogo; Yaakov Nahmias
Journal:  Annu Rev Biomed Eng       Date:  2019-06-04       Impact factor: 9.590

8.  Induction of Hepatic and Endothelial Differentiation by Perfusion in a Three-Dimensional Cell Culture Model of Human Fetal Liver.

Authors:  Christopher Pekor; Jörg C Gerlach; Ian Nettleship; Eva Schmelzer
Journal:  Tissue Eng Part C Methods       Date:  2015-02-11       Impact factor: 3.056

9.  The nitric oxide donor S-nitrosoglutathione reduces apoptotic primary liver cell loss in a three-dimensional perfusion bioreactor culture model developed for liver support.

Authors:  Jose M Prince; Yoram Vodovotz; Matthew J Baun; Satdarshan Pal Monga; Timothy R Billiar; Jörg C Gerlach
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

10.  Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils.

Authors:  Miho Tamai; Eijiro Adachi; Yoh-ichi Tagawa
Journal:  Tissue Eng Part A       Date:  2013-08-24       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.